Concepts (104)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Point-of-Care Systems | 5 | 2022 | 115 | 2.300 |
Why?
|
| Foreign Bodies | 2 | 2022 | 58 | 1.510 |
Why?
|
| Ultrasonography | 5 | 2022 | 453 | 1.180 |
Why?
|
| Gastrointestinal Contents | 2 | 2022 | 13 | 0.930 |
Why?
|
| Numismatics | 1 | 2022 | 5 | 0.850 |
Why?
|
| Thrombophlebitis | 1 | 2022 | 47 | 0.830 |
Why?
|
| Soft Tissue Infections | 1 | 2022 | 19 | 0.830 |
Why?
|
| Rupture | 1 | 2021 | 29 | 0.770 |
Why?
|
| Pregnancy, Ectopic | 1 | 2021 | 16 | 0.760 |
Why?
|
| Venous Thrombosis | 1 | 2022 | 125 | 0.760 |
Why?
|
| Anesthesia | 1 | 2022 | 120 | 0.720 |
Why?
|
| Foot | 1 | 2020 | 66 | 0.690 |
Why?
|
| Nerve Block | 1 | 2020 | 55 | 0.670 |
Why?
|
| Ultrasonography, Interventional | 1 | 2020 | 119 | 0.670 |
Why?
|
| Emergency Service, Hospital | 2 | 2022 | 711 | 0.250 |
Why?
|
| Child | 3 | 2022 | 6405 | 0.210 |
Why?
|
| Esophagoscopy | 1 | 2022 | 72 | 0.210 |
Why?
|
| Pediatric Emergency Medicine | 1 | 2022 | 14 | 0.210 |
Why?
|
| Jugular Veins | 1 | 2022 | 37 | 0.210 |
Why?
|
| Emergency Medicine | 1 | 2022 | 88 | 0.200 |
Why?
|
| Conscious Sedation | 1 | 2022 | 61 | 0.190 |
Why?
|
| Humans | 9 | 2022 | 68618 | 0.190 |
Why?
|
| Anesthesia, General | 1 | 2020 | 86 | 0.170 |
Why?
|
| Adolescent | 2 | 2021 | 8912 | 0.150 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2011 | 231 | 0.140 |
Why?
|
| Pregnancy | 1 | 2021 | 2334 | 0.130 |
Why?
|
| Female | 4 | 2022 | 38074 | 0.120 |
Why?
|
| Prospective Studies | 1 | 2022 | 3705 | 0.120 |
Why?
|
| Colorimetry | 1 | 2011 | 22 | 0.100 |
Why?
|
| Molecular Imaging | 1 | 2011 | 45 | 0.100 |
Why?
|
| Neoplasms, Experimental | 1 | 2011 | 118 | 0.090 |
Why?
|
| Liposomes | 1 | 2011 | 107 | 0.090 |
Why?
|
| Retrospective Studies | 1 | 2022 | 7277 | 0.090 |
Why?
|
| Nitric Oxide | 1 | 2011 | 382 | 0.080 |
Why?
|
| Oxidative Stress | 2 | 2011 | 718 | 0.080 |
Why?
|
| MicroRNAs | 1 | 2011 | 447 | 0.070 |
Why?
|
| Inflammation | 1 | 2011 | 1030 | 0.060 |
Why?
|
| Food Irradiation | 1 | 2004 | 1 | 0.060 |
Why?
|
| Malus | 1 | 2004 | 4 | 0.060 |
Why?
|
| Escherichia coli O157 | 1 | 2004 | 10 | 0.060 |
Why?
|
| Beverages | 1 | 2004 | 50 | 0.060 |
Why?
|
| Glutathione Peroxidase | 1 | 2004 | 39 | 0.060 |
Why?
|
| SAIDS Vaccines | 1 | 2003 | 2 | 0.060 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 2003 | 29 | 0.060 |
Why?
|
| Simian Immunodeficiency Virus | 1 | 2003 | 28 | 0.060 |
Why?
|
| Superoxide Dismutase | 1 | 2004 | 149 | 0.060 |
Why?
|
| Bacillus | 1 | 2003 | 5 | 0.050 |
Why?
|
| Polymyxins | 1 | 2003 | 3 | 0.050 |
Why?
|
| Adenoviridae | 1 | 2003 | 295 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2022 | 62 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 2223 | 0.050 |
Why?
|
| Bacteria | 1 | 2003 | 193 | 0.050 |
Why?
|
| Health Services Research | 1 | 2022 | 209 | 0.050 |
Why?
|
| Escherichia coli | 1 | 2003 | 368 | 0.050 |
Why?
|
| Male | 1 | 2022 | 37321 | 0.040 |
Why?
|
| Apoptosis | 1 | 2004 | 1641 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2011 | 346 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2003 | 1026 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2011 | 2791 | 0.030 |
Why?
|
| Nitrosation | 1 | 2011 | 2 | 0.030 |
Why?
|
| Propionibacterium acnes | 1 | 2011 | 10 | 0.020 |
Why?
|
| Lymphoma | 1 | 2011 | 116 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2011 | 201 | 0.020 |
Why?
|
| Mice | 2 | 2011 | 8474 | 0.020 |
Why?
|
| Contrast Media | 1 | 2011 | 595 | 0.020 |
Why?
|
| Animals | 3 | 2011 | 20881 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2011 | 1692 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2011 | 1851 | 0.020 |
Why?
|
| Malates | 1 | 2004 | 5 | 0.020 |
Why?
|
| Food Microbiology | 1 | 2004 | 24 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2004 | 75 | 0.010 |
Why?
|
| Species Specificity | 1 | 2004 | 303 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 2004 | 119 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2004 | 130 | 0.010 |
Why?
|
| Catalase | 1 | 2004 | 85 | 0.010 |
Why?
|
| Gene Products, env | 1 | 2003 | 3 | 0.010 |
Why?
|
| Gene Products, gag | 1 | 2003 | 11 | 0.010 |
Why?
|
| Gene Products, rev | 1 | 2003 | 8 | 0.010 |
Why?
|
| Immunization, Secondary | 1 | 2003 | 17 | 0.010 |
Why?
|
| Vaccines, Synthetic | 1 | 2003 | 19 | 0.010 |
Why?
|
| Administration, Rectal | 1 | 2003 | 26 | 0.010 |
Why?
|
| Immunity, Mucosal | 1 | 2003 | 19 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 2003 | 77 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2003 | 62 | 0.010 |
Why?
|
| Viral Envelope Proteins | 1 | 2003 | 43 | 0.010 |
Why?
|
| RNA, Viral | 1 | 2003 | 93 | 0.010 |
Why?
|
| Immunization | 1 | 2003 | 86 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2004 | 618 | 0.010 |
Why?
|
| Virus Replication | 1 | 2003 | 104 | 0.010 |
Why?
|
| Doxorubicin | 1 | 2004 | 231 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2004 | 282 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 2003 | 110 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2003 | 226 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2003 | 150 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2003 | 362 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2004 | 682 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2004 | 499 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2003 | 370 | 0.010 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2003 | 306 | 0.010 |
Why?
|
| Calcium | 1 | 2004 | 929 | 0.010 |
Why?
|
| Cell Line | 1 | 2004 | 1752 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2004 | 1664 | 0.010 |
Why?
|
| Mitochondria | 1 | 2004 | 643 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2004 | 902 | 0.010 |
Why?
|